This is Thomas Sullivan - Policy & Medicine Writing Staff's Typepad Profile.
Join Typepad and start following Thomas Sullivan - Policy & Medicine Writing Staff's activity
Join Now!
Already a member? Sign In
Thomas Sullivan - Policy & Medicine Writing Staff
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports, medical education, track and cross country, driving kids to various practices
Recent Activity
Image
“We will see those prices go down, it will be a beautiful thing to watch.” President Donald J. Trump In less than twenty-five minutes, President Donald J. Trump and Health and Human Services (“HHS”) Secretary Alex Azar provided their remarks... Continue reading
Posted May 14, 2018 at Policy and Medicine
Image
“We will see those prices go down, it will be a beautiful thing to watch.” President Donald J. Trump In less than twenty-five minutes, President Donald J. Trump and Health and Human Services (“HHS”) Secretary Alex Azar provided their remarks... Continue reading
Posted May 12, 2018 at Policy and Medicine
Image
On May 2, 2018, three law firms filed class action lawsuits against pharmaceutical manufacturers and distributors on behalf of individuals and businesses who have been handed higher insurance costs as a result of the opioid epidemic. The law firms filed... Continue reading
Posted May 11, 2018 at Policy and Medicine
Image
The IQVIA Institute for Human Data Science recently released a report focused on net spending on medicines in the United States in 2017, with an outlook to 2022. The report notes that spending on medicines grew less than one percent... Continue reading
Posted May 10, 2018 at Policy and Medicine
Image
On Thursday, April 26, 2018, Centers for Medicare and Medicaid Services Administrator Seema Verma announced the Agency’s new Data Driven Patient Care Strategy, as part of the MyHealthEData initiative. CMS is hoping to make its data more accessible and usable... Continue reading
Posted May 9, 2018 at Policy and Medicine
Image
Many states have taken the cue from the federal government and started their own investigation and research into opioids and the way opioids affect their particular state. Recently, Oklahoma joined the ranks of the states who have not just looked... Continue reading
Posted May 8, 2018 at Policy and Medicine
Image
House of Representatives member Representative Susan W. Brooks recently introduced the ADAPT Act of 2018. The ADAPT Act (Abuse Deterrent and Prescriber Training Act of 2018) is an attempt to require training for prescribers of controlled substances. The bill would... Continue reading
Posted May 7, 2018 at Policy and Medicine
Image
Recently, the Accreditation Council for Continuing Medical Education (ACCME) held its March meetings with its Board of Directors, during which the Board adopted a new strategic plan. The new strategic plan discusses the ACCME’s goals to drive transformation in the... Continue reading
Posted May 4, 2018 at Policy and Medicine
Image
We try to keep our readers in the loop with transparency and other related legislation that are happening throughout the country. On May 1, 2018, the governor of Maine, Paul LePage, allowed legislation to pass into law without his signature... Continue reading
Posted May 3, 2018 at Policy and Medicine
Image
On Monday, April 16, 2018, the United States Supreme Court denied a request by Johnson & Johnson to review a whistleblower case against the company’s subsidiary, DePuy Orthopaedics, Inc.. Johnson & Johnson requested that the high court review a July... Continue reading
Posted May 2, 2018 at Policy and Medicine
Image
On April 13, 2018, the United States of Appeals for the Fourth Circuit struck down the first-in-the-nation law aimed at lowering the price of off-patent or generic drugs. The Court, in a two-to-one ruling, stated the law is in violation... Continue reading
Posted May 1, 2018 at Policy and Medicine
Image
In March 2018, the National Quality Forum (NQF) released a guide for healthcare providers, the National Quality Partners PlaybookTM: Shared Decision Making in Healthcare. This recently-released Playbook offers vital guidance for the process of making shared decision making a standard... Continue reading
Posted Apr 30, 2018 at Policy and Medicine
Image
We have been keeping up with proposed and passed legislation in several states that affect the pharmaceutical industry, especially those relating to drug price transparency. Many states over the past couple of years have been tweaking their rules regarding industry... Continue reading
Posted Apr 27, 2018 at Policy and Medicine
Image
On April 9, 2018, the United States Food and Drug Administration issued an order restricting the sale and distribution of the Essure permanent contraception device. The FDA took this step once it became aware that some women were not “adequately... Continue reading
Posted Apr 26, 2018 at Policy and Medicine
Image
On April 4, 2018, a lawsuit was unsealed that shows McKesson Corporation – America’s largest drug distributor and one of the top five largest public companies of any kind in America – is being accused of illegally pooling leftover cancer... Continue reading
Posted Apr 25, 2018 at Policy and Medicine
Image
As discussed in several news outlets, the Trump Administration recently announced that it would begin to enforce long-standing administrative law principles and limit the weight guidance documents carry in government actions against private companies and individuals. While the ramifications of... Continue reading
Posted Apr 25, 2018 at Policy and Medicine
Image
On April 10, 2018, Numerof & Associates released its third annual national study of population health adoption. The report provides a national in-depth look at the pace of transition from fee-for-service models to models that are based on fixed payments... Continue reading
Posted Apr 24, 2018 at Policy and Medicine
Image
On June 11th and 12th, 2018, the Ninth Aggregate Spend and Open Payments Conference will be held in Philadelphia, Pennsylvania at the Sonesta Philadelphia Hotel Rittenhouse Square. The organizers of the event recognize the importance of transparency reporting and the... Continue reading
Posted Apr 24, 2018 at Policy and Medicine
Image
Vermont Senator and former Democratic presidential candidate Bernie Sanders introduced a bill into the United States Senate on April 17, 2018, that would impose jail time on pharmaceutical executives whose companies engage in manipulative practices when marketing opioids. The bill,... Continue reading
Posted Apr 23, 2018 at Policy and Medicine
Image
In the most recent chapter in the ongoing battle over the priority of patient assistance programs, the Caring Voice Coalition recently announced it would not provide financial assistance for any diseases in 2018. As a result of this announcement, HHS... Continue reading
Posted Apr 23, 2018 at Policy and Medicine
Image
Nine of the nation’s leading physician groups – including the American College of Rheumatology, American Academy of Neurology, American Academy of Ophthalmology, and American Urological Association – joined together this week to urge the Trump Administration to reconsider some of... Continue reading
Posted Apr 20, 2018 at Policy and Medicine
Image
U.S. ex rel. Ruckh v. CMC II LLC et al. (“Ruckh”) was a closely followed False Claims Act case, because a Florida Federal Court opted to vacate a nearly $350 Million FCA verdict involving a nursing home operator. The case... Continue reading
Posted Apr 20, 2018 at Policy and Medicine
Image
In mid-March 2018, five New York City doctors were arrested and charged with accepting bribes and kickbacks from Insys Therapeutics to prescribe high volumes of Subsys, a fentanyl-based cancer pain medicated spray. The five doctors – Gordon Freedman, 57, of... Continue reading
Posted Apr 19, 2018 at Policy and Medicine
Image
On Wednesday, April 4, 2018, Food and Drug Administration (FDA) Commissioner Scott Gottlieb spoke at the National Rx Drug Abuse and Heroin Summit. Gottlieb opened by comparing recent opioid deaths to those that happened at the peak of the AIDS... Continue reading
Posted Apr 18, 2018 at Policy and Medicine
Image
In a closely watched matter culminating years of litigation, Medtronic on December 12, 2017, entered into a $12 Million multi-state settlement resolving allegations that the medical device company had misled consumers about the safety, efficacy, and effectiveness of its Infuse®... Continue reading
Posted Apr 18, 2018 at Policy and Medicine